TK and nuclear hormone receptors Flashcards

1
Q

Tyrosine kinase has a double extracellular region (N terminal). True or false?

A

False - single extracellular region

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The extracellular region includes binding site for ____________

A

chemical messenger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

It has a single hydrophobic region that traverses the membrane as an alpha helix of ____ turns

A

7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The C-terminal chain is inside the cell membrane and acts as a _________

A

catalytic binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TK receptors have a dual role. They act as _______ and _______

A

enzymes

receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In the resting state, does the receptor have any catalytic activity?

A

No - the active site is hidden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens when the ligand binds to the receptor?

A

The receptor changes shape and reveals the active site on the C-terminal chain - phosphorylation can now occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is required to supply the phosphate?

A

ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EGF is a bivalent ligand. What is meant by this?

A

It can bind two receptors at the same time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens when EGF binds receptors?

A

Results in receptor dimerisation and activation of enzyme activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phosphorylation can take place even if dimerisation doesn’t occur. True or false?

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Some insulin receptors already exists as dimers or trimers and only require the binding of a ligand. True or false?

A

False - exists as dimers or tetramers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The insulin receptor is a homotetrameric complex which acts as a TK receptor, True or false?

A

False - heterotetrameric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference between TK receptors and TK linked receptors?

A

TK linked receptors require an extra step because they do not have catalytic activity in their C terminal chain. Ligands can bind and dimerise and then activate a TK enzyme from the cytoplasm (extra step)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Once the kinase receptor has been phosphorylated, the phospho-tyrosine groups acts as binding sites for ____________

A

signalling proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

signalling proteins cannot become phosphorylated. True or false?

A

False - they can become phosphorylated and act as further binding sites

17
Q

What determines the type of signalling that takes place?

A

The protein that has managed to bind to the kinase receptors

18
Q

Some growth factors activate _________ leading to calcium release

A

phospholipase C

19
Q

Some TK receptors can catalyse the formation of ____ from GTP

A

cGMP

20
Q

cGMP opens _______ channels in the kidney which promote the excretion of _______

A

sodium

sodium

21
Q

TK receptors are more important than GPC receptors. True or false?

A

False - second most important drug targets after GPC

22
Q

Which human diseases is kinase activity implicated?

A

Cancer
Rheumatoid arthiritis
Asthma
Psoriasis

23
Q

How can modulation of kinase activity be achieved?

A

Inhibition of phosphorylation activity by blocking ATP binding
Disruption of protein-protein interactions
Down-regulation of kinase gene expression

24
Q

Which drug inhibits abnormal kinase in chronic myeloid leukaemia?

A

Imatinib mesylate

25
Q

Which two drugs target ATP binding to EGFR (which is overexpressed in tumours)?

A

Gefitinib

Erlotinib

26
Q

Which two drugs block the receptor protein kinase?

A

Cetuximab

Panitumumab

27
Q

Which drug blocks a ligand from binding to receptors?

A

Bevacizunam